Allurion Technologies, Inc. is a pioneering healthcare company headquartered in Natick, Massachusetts, that is revolutionizing the treatment of obesity with its innovative weight loss platform. Its flagship product, the Elipse Balloon, is a non-surgical solution that enables patients to achieve significant, sustainable weight loss while fitting seamlessly into their lifestyles. With a strong focus on clinical excellence and user experience, Allurion is poised to capitalize on the growing global demand for effective obesity treatments, positioning itself as a crucial player in the dynamic medtech sector. As the company continues to advance its technology and expand its market presence, it is well-equipped to drive substantial growth and contribute to improved health outcomes worldwide. Show more
Location: 11 HURON DRIVE, NATICK, MA, UNITED STATES, 01760, Natick, MA, 01760, USA | Website: https://www.allurion.com | Industry: MEDICAL DEVICES | Sector: HEALTHCARE
Market Cap
18.68M
52 Wk Range
$1.02 - $7.12
Previous Close
$1.52
Open
$1.54
Volume
29,111
Day Range
$1.47 - $1.54
Enterprise Value
45.92M
Cash
6.136M
Avg Qtr Burn
-6.544M
Insider Ownership
6.37%
Institutional Own.
54.53%
Qtr Updated
09/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
We track quarterly 13F filings for some of the largest biotech hedge funds here.
